Current perspective of information technologies in drug discovery Ferran SanzFederico Gago OriginalPaper Pages: 767 - 768
Binding models of reversible inhibitors to type-B monoamine oxidase Antonio CarrieriAndrea CarottiCosimo Altomare OriginalPaper Pages: 769 - 778
Molecular dynamics simulation of the ligand binding domain of mGluR1 in response to agonist and antagonist binding Gabriele CostantinoAntonio MacchiaruloRoberto Pellicciari OriginalPaper Pages: 779 - 784
Similarity based SAR (SIBAR) as tool for early ADME profiling Christian KleinDominik KaiserGerhard F. Ecker OriginalPaper Pages: 785 - 793
A model of the human M2 muscarinic acetylcholine receptor Kirstin JöhrenHans-Dieter Höltje OriginalPaper Pages: 795 - 801
Classification scheme for the design of serine protease targeted compound libraries Stanley A. LangAndrey V. KozyukovNikolay P. Savchuk OriginalPaper Pages: 803 - 807
Distant collaboration in drug discovery: The LINK3D project Manuel PastorPaolo Benedettithe LINK3D Consortium OriginalPaper Pages: 809 - 818
How to acquire new biological activities in old compounds by computer prediction V.V. PoroikovD.A. Filimonov OriginalPaper Pages: 819 - 824
Development of biologically active compounds by combining 3D QSAR and structure-based design methods Wolfgang Sippl OriginalPaper Pages: 825 - 830
Protein Alpha Shape Similarity Analysis (PASSA): A new method for mapping protein binding sites. Application in the design of a selective inhibitor of Tyrosine kinase 2 Kristin TøndelEndre AnderssenFinn Drabløs OriginalPaper Pages: 831 - 840
Key issues in the computational simulation of GPCR function: representation of loop domains E.L. MehlerX. PerioleH. Weinstein OriginalPaper Pages: 841 - 853